Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients With T790M

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study is conducted to evaluate the efficacy and safety of Alflutinib in locally advanced or metastatic non-small cell lung cancer patients harbouring T790M mutation
Epistemonikos ID: 6ea50114b8efce7d38a075bc02335c8424a189b1
First added on: May 21, 2024